2023 CBIIC in Suzhou Industrial Park on September 25-27, 2023.
Zhimin Yang, chief pharmacist, pediatrics physician.
Dr Yang is deputy director, and the leader of the Medical Review Department I, Centre for Drug Evaluation (CDE), China National Medical Products Administration (NMPA). She graduated from Peking University Medical School, and worked as pediatrics physician in People’s Hospital (Peking University Medical School) for 8 years since 1993, she joined in CDE as medical review in 2001, now is with more than 15 years experience of medical review. Dr Yang’s department is responsible for the medical evaluation of the therapeutic drugs of cancer, leukemia, diabetes, rheumatoid arthritis etc. Dr. Yang received long course system training of new drug development and review in Australia and the United States of America. She leaded multiple guidances clinical development of new drugs, and is the vice chairman of Clinical Trial Committee Chinese Anti-Cancer Association. She is the professor of ICH E11a and ICH E6R3, and a member of China Science Committee of ICH. She was awarded with special allowance of the State Concil.